Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00064246
Status:
COMPLETED
Last Update Posted:
2013-01-25
First Post:
2003-07-08
Brief Title:
Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder
Sponsor:
Organization:
National Cancer Institute NCI